Familial hypomagnesemia is a rare human disorder caused by renal or intestinal magnesium (Mg 2þ ) wasting, which may lead to symptoms of Mg 2þ depletion such as tetany, seizures, and cardiac arrhythmias. , and its basolateral localization signify a critical role for CNNM2 in epithelial Mg 2þ transport.
Introduction
Magnesium (Mg 2þ ) plays a crucial role in many biological processes such as enzyme and muscular function and neuronal transmission. In adults, the normal serum Mg 2þ concentration ranges from 0.7 to 1.2 mmol/l. well-characterized upregulated transcripts, one of which encodes CNNM2 (previously known as ACDP2). 14 The
Cnnm2 transcript caught our interest because it has been shown to be upregulated in mice kept on a low-Mg 2þ diet and in mouse DCT cells grown in low-Mg 2þ -containing media. 15 Moreover, when expressed in Xenopus laevis oocytes, CNNM2 induced the transport of a range of divalent cations, including Mg 2þ but not Ca 2þ . 15 In the present study, we investigated CNNM2 (MIM 607803) as a candidate gene for unresolved human Mg 2þ wasting phenotypes and identified mutations in two unrelated families with dominant hypomagnesemia.
Subjects and Methods

Patients
Informed consent to participate in this study was obtained from the patients and their participating relatives. The procedures followed were in accordance with the standards of the medical ethics committee of each participating institution.
Family A Details of the index patient and her father have been extensively described elsewhere. 16 In brief, in both individuals ( Figure 1A 
Mutation Analysis
Genomic DNA from peripheral blood was isolated using standard methods. After previous exclusion of mutations in FXYD2, EGF, and SLC12A3 (MIM 600968) (data not shown), individuals from a Dutch family (Family A, Figure 1A , I.1, II.3, and III.2) and a family from the Czech Republic (Family B, Figure 1A , I.2 and II.1) were tested for mutations in the coding region of CNNM2 (NM_017649.3) by direct sequencing of amplified exonic PCR products. Primers were designed using Primer3 software. 17 Amplicons generated for sequencing included at least 80 nucleotides upstream and 30 nucleotides downstream of the exonic sequence to cover possible mutations in branch and splice sites. Primer sequences and PCR conditions are listed in Table S1 (available online). We checked for the absence of identified mutations in 202 and 214 ethnically matched control chromosomes in family A and family B, respectively.
Bioinformatics
We performed a multiple sequence alignment of the CNNM2 protein with its three human homologs and with six orthologs using ClustalW. For a prediction of the membrane topology, the following web services were used: Human Protein Atlas, TMHMM Server v. 2.0, and Consensus Prediction of Membrane Protein Topology. Protein signatures were determined using the InterPro database.
Antibody Generation
A guinea pig anti-CNNM2 polyclonal antibody directed against the CNNM2-specific peptide CGLNHSDSLSRSDRI, corresponding to amino acids 754-768 of both the human and mouse protein, was generated by Biogenes (Berlin, Germany). In brief, guinea pigs were injected on day 1 with 0.5 mg synthetic peptide conjugated with the carrier protein Limulus polyphemus hemocyanin, and preimmune serum was withdrawn. Subsequent boosts of 1 3 0.25 mg and 3 3 0.125 mg peptide were performed on days 14, 28, 56, and 84, followed by a final bleeding on day 98. The antibody response in the serum from the final bleeding was compared with antibody response from the preimmune serum from the same animal to ensure specificity ( Figure S1 ).
Immunohistochemistry
Four percent (w/v) paraformaldehyde fixed and paraffin-embedded human kidney sections from healthy human kidneys were stained sequentially with the antibody against CNNM2 and an antibody against uromodulin/ Tamm Four-micrometer-thick sections of 4% (w/v) paraformaldehyde fixed and paraffin-embedded kidneys of C57BL/6 mice ( Figure S2 ) were similarly processed except that antibodies against CNNM2 and the nephron markers were not applied sequentially. Here, the primary antibodies were guinea pig anti-CNNM2 (1:100), rabbit anti-UMOD (Biomedical Technologies, 1:250), and rabbit anti-NCC (a kind gift from Dr. D.H. Ellison, 1:200). The secondary antibodies were Alexa Fluor 488 goat anti-guinea pig IgG and Alexa Fluor 594 goat anti-rabbit IgG (both Invitrogen, 1:500). Fluorescence microscopy of these sections was performed with a Leica DM IRE2 inverted microscope, and images were taken with Openlab software.
Cloning
To obtain CNNM2 expression constructs, we used the full-length murine Cnnm2 cDNA, RIKEN FANTOM clone 6330543C15, GenBank accession number AK032006.1. Compared to RefSeq NM_033569.3, it contained two errors in its coding region (c.560A>G [p.Lys187Arg] and c.1329delC [p.Lys444ArgfsX6], where þ1 is the A of the translation initiation codon). These were corrected using the QuikChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's protocols. This resulted in clone pFLCI-mCnnm2WT. To obtain a construct with the missense mutation c.1703C>T (p.Thr568Ile) found in family B, we performed another mutagenesis round, resulting in clone pFLCI-mCnnm2Mut.
For the generation of C-terminally HA-tagged eukaryotic expression constructs, the open reading frames of the two pFLCI clones were amplified using Phusion polymerase (Finnzymes) and primers For1 and Rev1 (Table S2) to introduce an in-frame HA tag before the stop codon and KpnI and XbaI restriction sites. The amplicons were cloned into pGEM-T easy (Promega) and subcloned into the pcDNA3 expression vector (Invitrogen) via the KpnI and XbaI restriction sites.
For cloning of wild-type and p.Thr568Ile mutant CNNM2 in the bicistronic-enhanced GFP expression vector pCINeo-IRES-GFP 18 and introduction of an in-frame C-terminal HA tag, the open reading frames of the two pFLCI clones were amplified using primers For2 and Rev2 (Table S2 ) and cloned using NheI and XhoI restriction sites.
All clones were sequence verified for the complete CNNM2 coding region.
Immunocytochemistry
Mouse distal convoluted tubule (mDCT) cells were kindly provided by Dr. P.A. Friedman (University of Pittsburgh School of Medicine, Pittsburgh, PA). The isolation and functional characterization of these cells has been described previously. 19, 20 The cells were grown in DMEM/Ham's F-12 media (Lonza, Verviers, Belgium), supplemented with 5% (v/v) fetal bovine serum (Lonza), 2 mM L-glutamine, 50 U/ml penicillin, and 50 mg/ml streptomycin in a humidified environment of 5% (v/v) CO 2 at 37 C.
Where indicated, subconfluent mDCT cells were cultured in Mg (Biocyc, Germany) for investigation under a Zeiss LSM 510 META confocal microscope (Jena, Germany). Images and videos were generated with LSM Image Browser software.
Quantitative Real-Time PCR mDCT cells were grown under control conditions or low-Mg 2þ or low-Ca 2þ conditions for 18 hr as described above. Total RNA was extracted via the RNAqueous-Micro kit (Ambion) according to the manufacturer's protocol. Quality and concentration of the isolated RNA preparations were analyzed using the 2100 Bioanalyzer (RNA Pico chip, Agilent Technologies, Palo Alto, CA). One microgram of RNA was used for reverse transcription using the iScript cDNA Synthesis Kit (Bio-Rad). Real-time PCR primers (Table S3) were designed using Primer3 software. 17 PCR reactions were performed on a CFX96 TM Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA). Reactions were done in duplicate using iQ TM SYBR Green Supermix (Bio-Rad) with primer concentrations of 100 nM in 20 ml reactions. PCR conditions were 95 C for 3 min followed by 40 cycles of 15 s at 95 C and 30 s at 60 C.
A single PCR product accumulation was detected and the PCR products were checked by sequencing. Relative changes in target gene/Gapdh mRNA ratio were determined by the formula 2 ÀDDCt .
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Comparable results were obtained when Actb was used as the reference gene (data not shown).
Electrophysiology
Human embryonic kidney (HEK) 293 cells seeded in 12-well plates were transfected, via Lipofectamine 2000, (Invitrogen) with 1 mg of pCINeo-IRES-GFP constructs encoding C-terminally HA-tagged wild-type or p.Thr568Ile mutant CNNM2. After 12 hr, transfected cells were plated at low density on glass coverslips coated with fibronectin (Roche). Cells were maintained at 37 C in DMEM and supplemented with 10% (v/v) fetal bovine serum, essential amino acids, and L-glutamine in 5% (v/v) CO 2 atmosphere. Patch-clamp experiments were performed under the whole-cell configuration with an EPC-9 patch-clamp amplifier controlled by the Pulse software (HEKA Elektronik, Germany). Borosilicate patch pipettes had resistances between 3 and 4 MU after they were filled with the intracellular solutions. Series resistances (3-10 MU) were continuously monitored with the automatic capacitance compensation of Pulse software. All patch-clamp experiments were performed at room temperature (21 C). To study Na þ -dependent inward currents from wild-type and mutant CNNM2-expressing cells, we applied a repetitive voltage ramp protocol consisting of À120 to þ80 mV over 450 ms duration every 2 s from a holding potential of 0 mV. The density current was obtained from the peak current at À110 mV and was normalized with the capacitance value of the cell obtained from the set-up. Extracellular solutions were (in mM) 80 Na 
Cell Surface Biotinylation and Immunoblotting
HEK293 cells were transfected with pCINeo/IRES-GFP constructs expressing HA-tagged wild-type or p.Thr568Ile mutant CNNM2, as described above. After 48 hr, cells surfaces were biotinylated with sulfo-NHS-LC-LC-biotin (Pierce, Rockford, IL, USA). Cells were lysed with a Triton-containing lysis buffer, and 5% of the protein amount was collected as a total sample. Subsequently, the biotinylated proteins of the remaining 95% were precipitated with NeutrAvidin-agarose beads (Pierce, Rockford, IL, USA). We resolved total protein and plasma membrane fractions by SDS-PAGE and analyzed CNNM2 expression by immunoblot analysis with mouse anti-HA antibodies for the input and the plasma membrane fraction (Cell Signaling Technology). Probing blots with anti-b-actin antibodies (Sigma) confirmed equal loading and the absence of cytosolic proteins in the biotinylated fraction.
Statistics
Data are expressed as the mean 5 standard error of the mean (SEM). Data in Figure 3A were analyzed with an unpaired Student's t test. Data in Figure 4C were analyzed with paired (0 versus 20 mM Mg 2þ ) and unpaired (wild-type versus mutant) Student's t tests. p values of less than 0.05 were considered significant.
Results
Mutations in CNNM2 Cause Dominant Hypomagnesemia Here, affected individuals of two unrelated families with dominant hypomagnesemia were tested for mutations in CNNM2. In both families, the index patient had severely lowered serum Mg 2þ levels (0.51 mmol/l and 0.36 mmol/l in family A and B, respectively) in the absence of other electrolyte disturbances. Affected individuals in both families showed an inappropriately normal urinary Mg 2þ excretion, demonstrating a defect in tubular reabsorption (details in Subjects and Methods). Mutation screening of CNNM2 (NM_017649.3) revealed a heterozygous 1 bp deletion, c.117delG in the index patient of family A, and a heterozygous missense mutation c.1703C>T in the index patient of family B ( Figure 1A) . In family A, the corresponding deletion was also detected in the father (II.3) but not in the grandfather (I.1) of the index patient. In family B, the mother (I.2) carried the same missense mutation as the index patient. Neither of the two mutations was found in more than 200 ethnically matched control chromosomes.
The 1 bp deletion c.117delG (p.Ile40SerfsX15) causes a frameshift and premature stop codon, leading to a truncated protein of 53 amino acids. The missense mutation c.1703C>T, causing a substitution of the threonine at position 568 with an isoleucine (p.Thr568Ile), is located in the most conserved region of CNNM2, termed ancient conserved domain (ACD) ( Figure 1B) . 23 A multiple sequence alignment of the CNNM2 protein with its three human homologs and with six orthologs down to the Salmonella bacterium ( Figure 1C) shows that the threonine at position 568 is highly conserved. One nonsynonymous SNP, c.113G>A (p.Arg38Gln), was detected in our patients. We confirmed it to be a SNP by testing control chromosomes (n ¼ 214), where it was found seven times. Moreover, it was also listed in the NCBI database of genetic variation (rs76057237, dbSNP build 131). conditions. Expression levels are normalized to those of Gapdh and shown as fold change difference compared to control conditions. n ¼ 6, data are shown as means 5 SEM. **p < 0.01; ***p < 0.001 compared to normal culture conditions. we were able to confirm the predominant basolateral localization of the CNNM2 protein ( Figure 3B ) that was increased in Mg 2þ -deprived cells. Unfortunately, the antibody against CNNM2 has proven unsuitable for confirming this result by immunoblot analysis. In addition, we performed in vitro expression studies by transient transfection of polarized Madin-Darby canine kidney (MDCK)-C7 cells with a vector encoding HA-tagged wild-type CNNM2. Again, we detected localization of CNNM2 at the (baso-)lateral membrane ( Figure 3C , left, and Movie S1). To test whether the missense mutation identified in family B affected the trafficking of the protein, we also expressed HA-tagged p.Thr568Ile mutant CNNM2 in MDCK-C7 cells ( Figure 3C , right, and Movie S2). No obvious difference in subcellular localization was observed between mutant and wild-type protein.
CNNM2 Is Localized on the Basolateral
Functional Characterization of CNNM2 and the p.Thr568Ile Mutant Next, we investigated the functional characteristics of CNNM2 by using patch-clamp analysis in the whole-cell configuration of HEK293 cells that were transiently -induced currents by CNNM2 expressed in X. laevis oocytes, we first applied a repetitive voltage ramps protocol in the presence of an increasing extracellular Mg 2þ gradient as the sole charge carrier (2 to 40 mM). However, neither an inward nor an outward increase in current was observed in HEK293 cells expressing CNNM2 when these were compared to mock transfected cells (data not shown). Rather, in the presence of 80 mM extracellular Na þ -gluconate and 20 mM MgSO 4 , a small Mg 2þ -sensitive Na þ current was observed at a holding potential of À110 mV, which was significantly and reversibly increased by removing extracellular MgSO 4 ( Figure 4A , average values shown in Figure 4C ). To disclose effects on the relatively small range currents (in the order of 20-100 pA/pF), we used To characterize the effect of the p.Thr568Ile mutation on CNNM2 activity, we applied the same protocol as described above using a construct encoding p.Thr568Ile mutant CNNM2 in which we sequentially applied an extracellular solution that either contained 20 mM MgSO 4 2.4 pA/pF in wild-type and mutant CNNM2, respectively ( Figure 4C ). In both cases, application of Zn 2þ produced a full block of the Na þ current ( Figure 4A ).
Wild-type and mutant CNNM2 protein were expressed in similar amounts on the surface of the HEK293 cells as demonstrated by a cell surface biotinylation assay followed by immunoblot analysis ( Figure 4D ). Equal loading of the blots and absence of cytosolic proteins in the biotinylated fraction were checked by staining with antibodies against b-actin ( Figure S3) . Thus, our results show that mutation of the threonine at position 568 to isoleucine causes a significant decrease in CNNM2 activity present at the plasma membrane.
Discussion
Here, we have identified mutations in CNNM2 in patients with dominant renal Mg 2þ wasting. In the kidney, CNNM2 is predominantly localized on the basolateral side of TAL and DCT, the major Mg 2þ -transporting nephron segments. The missense mutation found in our patients significantly impairs CNNM2 function as determined by electrophysiological analysis. CNNM2 (cyclin M2) is a member of a family of four proteins, CNNM1-4 (MIM 607802; 607804; 607805). 23 The name results from a weak sequence similarity that is shared with the cyclin family, although a cyclin-like function has never been shown for CNNM1-4. Within the CNNM family, CNNM2 is the most conserved between man and mouse, having a 99.1% similarity and 97.8% identity on the protein level. CNNM2 has 875 amino acids and is predicted to have four to five transmembrane domains and an extracellular C terminus ( Figure 1B) . In a secondary screen, the genome-wide association study also identified common variants in CNNM2 and other members of the CNNM gene family.
In the families with dominant Mg 2þ wasting presented here, we found two different types of mutation. In family A, we found an early frameshift, leading to a truncated protein of only 53 amino acids. In family B, we identified a substitution of a highly conserved amino acid that significantly impairs the function of the protein. Still, the affected individuals of both families display a nearly identical phenotype. Although this suggests to us that a reduced amount of functional protein may cause the disorder, the low number of patients does not allow us to make definite genotype-phenotype correlations, and we cannot rule out a dominant-negative effect. Future identification and analysis of additional families with mutations in CNNM2 will help to clarify this point. The biochemical findings between index patients and affected parents do not show marked differences. Notably, the serum Mg 2þ levels in both index patients and affected parents are in the same decreased range. What is remarkable, however, is the variability in the age of clinical (symptomatic) onset of the disease. In family A, the onset of the disease in the index patient was at two years of age, in her father it was at 15 years of age; in family B, the affected mother did not show any symptoms at all. This intrafamiliar variability in age of onset and/or severity of symptoms is a well-known phenomenon for dominant diseases. For example, this was also observed for other dominant hypomagnesemia disorders, such as the families with an FXYD2 mutation. 9, 30 The mechanism(s) underlying this phenomenon have not yet been elucidated, but it is likely that genetic modifying factors and/or environmental factors are involved. At present these putative genetic and environmental predisposing risk factors are completely unknown. Because CNNM2 expression is not restricted to the kidney (gene expression was reported to be ubiquitous and the highest levels were in kidney and brain), 15, 23, 31 we cannot exclude a contribution of other tissues to the observed hypomagnesemia in our patients. Importantly, however, the most prominent phenotype consists of a renal defect in Mg 2þ reabsorption, as shown by the inability of the kidney to reduce urinary Mg 2þ excretion under low serum Mg 2þ conditions. A tissue-specific phenotype was also observed for patients with mutations in CNNM4, a gene that is ubiquitously expressed as well. 23, 31 In this case, mutations lead to Jalili syndrome (MIM 217080), which features a phenotype restricted to the teeth (amelogenesis imperfecta) and eyes (cone-rod dystrophy). 32, 33 We hypothesize that a reduction in the amount of functional CNNM2 in our patients will be most noticeable in the renal epithelia that reabsorb high amounts of Mg 2þ .
In human and mouse kidney, we observed predominant CNNM2 expression in both TAL and DCT, the two consecutive nephron segments primarily responsible for Mg 2þ reabsorption. 1 The DCT has been shown to be the nephron Both in TAL and DCT, CNNM2 was found at the basolateral side of the epithelium, and this basolateral localization was confirmed for endogenous CNNM2 in mDCT cells. We showed that the localization of CNNM2 on the basolateral membrane was unchanged for the p.Thr568Ile mutant when CNNM2 was transiently expressed in polarized MDCK-C7 cells. Thus, we concluded that the missense mutation does not influence basolateral sorting of CNNM2 in this renal cell line.
For decades, biochemical studies have predicted that an active extrusion mechanism in the transcellular transport of Mg 2þ must exist, either via a Mg 2þ pump or a Na þ / Mg 2þ exchanger. 36 However, the molecular identity of such a transporter remains elusive. Although the finding of CNNM2 at the basolateral membrane could suggest an involvement in direct basolateral Mg 2þ extrusion, the Mg 2þ sensitivity of the Na þ currents suggests that, in mammalian cells, CNNM2 might contribute to a Mg 2þ -sensing mechanism rather than transporting Mg 2þ itself.
The tandem pair of CBS domains located in the highly conserved ACD might be directly involved in such a Mg 2þ -sensing mechanism. This might be comparable to the Mg 2þ -sensing mechanism of the bacterial Mg 2þ transporter MgtE, for which the crystal structure was recently solved 37 and in which the CBS domains might play an important role in Mg 2þ -sensing. 38 In conclusion, we identified mutations in CNNM2 associated with dominant hypomagnesemia by using a candidate gene approach. Future elucidation of the exact mechanism by which the basolaterally localized CNNM2 protein regulates renal Mg 2þ reabsorption will add fundamental insights to our understanding of kidney function and potentially lead to new therapeutic options.
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